Approach may offer new way to reverse disability in multiple sclerosis patients
A pair of topical medicines already alleviating skin conditions may prove to have another, even more compelling use: instructing stem cells in the brain to reverse damage caused by multiple sclerosis.
Led by researchers at Case Western Reserve University, a multi-institutional team used a new discovery approach to identify drugs that could activate mouse and human brain stem cells in the laboratory. The two most potent drugs—one that currently treats athlete’s foot, and the other, eczema—were capable of stimulating the regeneration of damaged brain cells and reversing paralysis when administered systemically to animal models of multiple sclerosis. The results were published online (dx.doi.org/10.1038/nature14335) Monday, April 20, in the scientific journalNature.
“We know that there are stem cells throughout the adult nervous system that are capable of repairing the damage caused by multiple sclerosis, but until now, we had no way to direct them to act,” said Paul Tesar, the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics, and associate professor in the Department of Genetics & Genome Sciences at the Case Western Reserve School of Medicine. “Our approach was to find drugs that could catalyze the body’s own stem cells to replace the cells lost in multiple sclerosis.”
The findings mark the most promising developments to date in efforts to help the millions of people around the world who suffer from multiple sclerosis. The disease is the most common chronic neurological disorder among young adults, and results from aberrant immune cells destroying the protective coating, called myelin, around nerve cells in the brain and spinal cord.
Without myelin, neural signals cannot be transmitted properly along nerves; over time, a patient’s ability to walk, hold a cup or even see is inexorably eroded. Current multiple sclerosis therapies aim to slow further myelin destruction by the immune system, but the Case Western Reserve team used a new approach to create new myelin within the nervous system. Their work offers great promise of developing therapies that reverse disabilities caused by multiple sclerosis or similar neurological disorders.
“To replace damaged cells, much of the stem cell field has focused on direct transplantation of stem cell-derived tissues for regenerative medicine, and that approach is likely to provide enormous benefit down the road,” said Tesar, also a New York Stem Cell Foundation Robertson Investigator and member of the National Center for Regenerative Medicine. “But here we asked if we could find a faster and less invasive approach by using drugs to activate native stem cells already in the adult nervous system and direct them to form new myelin. Our ultimate goal was to enhance the body’s ability to repair itself.”
Tesar emphasized that much work remains before multiple sclerosis patients might benefit from the promising approach. Scientists still must find ways to transform the topical medications for internal use and determine their long-term efficacy and potential side effects. That said, using existing, federally approved drugs enhances the likelihood that the compounds can be made safe for human use.
The Latest on: Multiple Sclerosis
via Google News
The Latest on: Multiple Sclerosis
- Share Your Christmas: Young moms battling multiple sclerosison November 28, 2020 at 7:37 pm
Today’s stories focus on two young women who are struggling to raise their children while the symptoms of multiple sclerosis progress. In this first family, Mom has found she can’t cope with worsening ...
- Multiple sclerosis may not put you at risk for breast, colorectal cancerson November 25, 2020 at 1:05 pm
People with multiple sclerosis (MS) may not be at higher risk of developing two of the three cancers that occur most commonly in people with MS, breast and colorectal cancer, than people who don't ...
- MediciNova's MN-166 can reduce retinal thinning in progressive multiple sclerosison November 25, 2020 at 8:58 am
(NASDAQ:MNOV) announces that positive Optical Coherence Tomography (OCT) results from the SPRINT-MS Phase 2b trial of MN-166 (ibudilast) in progressive multiple sclerosis (progressive MS) were ...
- 'Talking about it saves lives': Suicide survivor with multiple sclerosis shares her storyon November 24, 2020 at 2:37 am
Chloe Bellerby survived a suicide attempt as a teen, came from England to play soccer, and is an advocate for mental health and multiple sclerosis.
- Multiple Sclerosis Market Size Report 2020 Global Industry Analysis by Trends, Revenue, Share, Revenue and Forecast to 2025on November 23, 2020 at 2:54 am
Final Report will add the analysis of the impact of COVID-19 on this industry." “Multiple Sclerosis Market” has ...
- Gut-brain axis influences multiple sclerosison November 20, 2020 at 11:10 am
A Basel-led international research team has discovered a connection between the intestinal flora and sites of inflammation in the central nervous system in multiple sclerosis. A specific class of ...
- New research underscores the link between multiple sclerosis and the gut microbiomeon November 20, 2020 at 11:08 am
People with multiple sclerosis have elevated levels of immune cells in their brains that are associated with gut microbiota, the paper finds.
- 1 year after multiple sclerosis diagnosis, WTOP’s Dave Johnson looks back, forwardon November 19, 2020 at 2:06 am
One year after revealing he had been diagnosed with multiple sclerosis, WTOP’s Dave Johnson provides an update on his condition and outlook.
- The Challenges of Relapsing Multiple Sclerosis (MS) Can Add Upon November 18, 2020 at 4:23 am
From experiencing relapses, to worrying about what may come next and managing the demands of life around treatment schedules—the challenges of living with MS can really add up. When they do, it may be ...
- Multiple Sclerosis: Is Therapeutic Angiogenesis a Treatment or Even a Possible Cure?on November 17, 2020 at 9:22 pm
(Zhittya), a private company, announced that it will give a Webinar broadcast on its potential breakthrough therapy to reverse the progression of multiple sclerosis (MS).Currently, no therapies on the ...
via Bing News